Interní Med. 2010; 12(11): 565-569
The paper presents an overview of the research dealing with the effects of gliclazide MR in a number of aspects of the pathophysiology
of vascular changes in diabetes. The efficacy of this agent has been demonstrated by long-term use in the clinical practice; however,
gliclazide MR has certain exceptional pharmacological properties and haemovascular and antioxidative effects which distinguish it from
the other agents of the class of sulfonylurea derivatives. The development of vascular complications in diabetes is a complex process
involving a number of different but interrelated components, e.g. oxidative stress and endothelial dysfunction can be favourably affected
by treatment with gliclazide independently of improved diabetes compensation. In addition to the low potential for the development of
hypoglycaemias due to the favourable pharmacodynamic parameters of gliclazide MR, the positive cardiovascular outcomes reported
in clinical trials, particularly in the ADVANCE project, may be explained in this way.
Published: December 1, 2010 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...